ADHD and addiction;ADHS und sucht

PsychoNeuro

Volumn 31, Issue 11, 2005, Pages 554-562

  Ohlmeier, Martin ^a   Peters, Karsten ^a   Buddensiek, Nadine ^a   Seifert, Jürgen ^a   Te Wildt, Bert ^a   Emrich, Hinderk M ^a   Schneider, Udo ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ILLICIT DRUG;

ALCOHOLISM; ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; DISEASE EXACERBATION; EARLY DIAGNOSIS; HUMAN; MULTIPLE DRUG ABUSE; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SAMPLE SIZE; SUBSTANCE ABUSE;

EID: 28544438556     PISSN: 16119991     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-923369     Document Type: Review

References (31)

1. Barkley RA. Advancing age, declining ADHD; Am J Psychiatry 1997; 154 (9): 1323-5
2. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric Comorbidity. Am J Psychiatry 1995; 152: 1652-1658
3. Biederman J, Wilens TE, Mick E, Faraone SV, Spencer T. Does attention-deficit hyperactivity disorder impact the developmental course of drug and alcohol abuse and dependence? Biol Psychiatry 1998; 44: 269-273
4. Biederman J, Wilens T, Mick E, Spencer T, Faraone SV. Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder. Pediatrics 1999; 104: e20
5. Carroll KM, Rounsaville BJ. History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Compr Psychiatry 1993; 34: 75-82
6. Caspers-Merk M. Aufmerksamkeitsdefizit- und Hyperaktivitätssyndrom: Keine "Modeerkrankung". Positionspapier des Bundesgesundheitsamtes. Deutsches Ärzteblatt 99, Heft 24 vom 14.06.02, Seite A-1644
7. Conners CK, Levin ED, Sparrow E, Hinton SC, Erhardt D, Meek WH, Rose JE, March J. Nicotine and attention in adult attention deficit hyperactivity disorder (ADHD). Psychopharmacol Bull 1996; 32: 67-73
8. Conners CK, Erhardt D, Sparrow E. Conners' Adult ADHD Rating Scales (CAARS). North Tonawanda, NY. Multi-Health Systems, 1999
9. Diagnostic and statistical manual of mental disorders, 4th edn: DSM-IV. American Psychiatric Association, Washington DC., 1994
10. Dougherty DD, Bonab AA, Spencer TJ, Rauch SL, Madras BK, Fischman AJ. Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 1999; 354: 2132-2133
11. Dresel SHJ, Kung MP, Huang XF, Plössl K, Hou C, Meegalla SK, Patselas G, Mu M, Saffer JR, Kung HF. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons. J Nucl Med 1999; 40: 660-666
12. Ernst M, Zametkin AJ, Matochik JA, Jons PH, Cohen RM. DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18] fluorodopa positron emission tomographic study. J Neurosci 1998; 18: 5901-5907
13. th International Congress of European Child and Adolescent Psychiatry 1999; 8(Suppl 2): 126
14. Retz-Junginger P, Retz W, Blocher D, Weijers HG, Trott GE, Wender PH, Rossler M. Wender Utah Rating Scale (WURS-k). Die deutsche Kurzform zur retrospektiven Erfassung des hyperkinetischen Syndroms bei Erwachsenen. Nervenarzt 2002; 73 (9): 830-8
15. Krause KH, Krause J, Trott GE. Das hyperkinetische Syndrom (Aufmerksamkeits-defizit-/Hyperaktivitätsstörung des Erwachsenenalters). Nervenarzt 1998: 543-556
16. Krause KH, Dresel SH, Krause J, Kung HF, Tatsch K, Ackenheil M. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int J Neuropsychopharmacol. 2002; 5 (2): 111-113
17. Levin ED, Conners CK, Sparrow E, Hinton SC, Erhardt D, Meek WH, Rose JE, March J. Nicotine effects on adults with attention-deficit/hyperactivity disorder. Psychopharmacology 1996; 123: 55-63
18. Levin ED, Rezvani AH. Development of nicotinic drug therapy for cognitive disorders. Eur J Pharmacol 2000; 393: 141-146
19. Levin FR, Evans SM, Kleber HD. Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug Alcohol Depend 1998; 52: 15-25
20. Levin FR, Evans SM, McDowell DM, Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: a pilot study. J Clin Psychiatry 1998; 59 (6): 300-5
21. Loney J. Substance abuse in adolescents: diagnostic issues derived from studies of attention deficit disorder with hyperactivity, NIDA Res Monogr. 1988; 77: 19-26
22. Lou HC, Henriksen L, Bruhn P, Borner H, Bieber Nielsen J. Striatal dysfunction in attention deficit and hyperkinetic disorder. Arch Neurol 1989; 46: 48-52
23. Pomerleau OF, Downey KK, Stelson FW, Pomerleau CS. Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. J Subst Abuse 1995; 7: 373-378
24. Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 1996 18; 382 (6588): 255-7
25. Riggs PD, Leon SL, Mikulich SK, Pottle LC An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder. J Am Acad Child Adolesc Psychiatry. 1998; 37 (12): 1271-8
26. Riggs PD, Mikulich SK, Whitmore EA, Crowley TJ. Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug Alcohol Depend 1999; 54 (3): 195-205
27. Schubiner H, Tzelepis A, Milberger S, Lockhart N, Kruger M, Kelley BJ, Schoener EP. Prevalence of attention-deficit/hyperactivity disorder and conduct disorder among substance abusers. J Clin Psychiatry 2000; 61 (4): 244-51
28. Schubiner H, Saules KK, Arfken CL, Johanson CE, Schuster CR, Lockhart N, Edwards A, Donlin J, Pihlgren E. Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Exp Clin Psychopharmacol 2002; 10: 286-294
29. Wender PH. Attention-deficit disorder in adults. New York, Oxford, Oxford University Press, 1995
30. Wilens, TE, Biederman J, Mick E, Faraone SV. Attention deficit hyperactivity disorder (ADHD) is associated with early onset substance disorders. J Nerv Ment Dis 1997; 185: 475-48
31. Volkow ND, Wang GJ, Ma Y, Fowler JS, Zhu W, Maynard L, Telang F, Vaska P, Ding YS, Wong C, Swanson JM. Expectation enhances the regional brain metabolic and the reinforcing effects of stimulants in cocaine abusers. J Neurosci 2003; 23 (36): 11461-8